In vivo profiling of estrogen receptor/specificity protein-dependent transactivation

Endocrinology

Volumn 149, Issue 11, 2008, Pages 5696-5705

  Wu, Fei ^a   Xu, Rui ^a   Kim, Kyounghyun ^c   Martin, James ^c   Safe, Stephen ^b,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; LUCIFERASE; NONYLPHENOL; TATA BINDING PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS, NON-STEROIDAL; FEMALE; GC RICH SEQUENCE; GENE EXPRESSION PROFILING; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PHENOLS; TISSUE DISTRIBUTION; TRANSCRIPTIONAL ACTIVATION;

EID: 54349086566     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0720     Document Type: Article

References (66)

1. Clark JH 1998 Female reproduction and toxicology of estrogens. In: Korach KS, ed. Reproductive and developmental toxicology. New York: Marcel Dekker; 259-275
2. Chow J, Tobias JH, Colston KW 1992 Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89:74-78
3. Farhat MY, Lavigne MC, Ramwell PW 1996 The vascular protective effects of estrogen. FASEB J 10:615-624
4. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 15:275-300
5. Beatson GT 1986 On the treatment of inoperable cases of carcinoma of the mamma; suggestions for a new method of treatment with illustrative cases. Lancet 2:104-107
6. Kuschel B, Betz B, Niederacher D, Beckmann MW 2000 Hereditary breast cancer: molecular and chemical differences from sporadic breast cancer. J Women's Cancer 2:93-100
7. Hulka BS 1997 Epidemiologic analysis of breast and gynecologic cancers. In: Aldaz M, Gould MN, McLachlan J, Slaga TJ, eds. Etiology of breast and gynecological cancers. New York: Wiley-Liss; 17-29
8. Hulka BS, Liu ET, Lininger RA 1994 Steroid hormones and risk of breast cancer. Cancer 74:1111-1124
9. Hulka BS 1995 Breast cancer: cause and prevention. Lancet 346:883-887
10. Jordan VC 2003 Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J Med Chem 46:1081-1111
11. Jordan VC 2003 Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. J Med Chem 46:883-908
12. Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR 2004 Estrogen plus progestin and risk of venous thrombosis. JAMA 292:1573-1580
13. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
14. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH 2004 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2947-2958
15. Cowley SM, Hoare S, Mosselman S, Parker MG 1997 Estrogen receptors α and β form heterodimers on DNA. J Biol Chem 272:19858-19862
16. Hyder SM, Chiappetta C, Stancel GM 1999 Interaction of human estrogen receptors α and β with the same naturally occurring estrogen response elements. Biochem Pharmacol 57:597-601
17. Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU 1986 An estrogen-responsive element derived from the 5′-flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053-1061
18. Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S 1997 Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J Biol Chem 272:25832-25838
19. Blobel GA, Orkin SH 1996 Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol 16:1687-1694
20. Delfino F, Walker WH 1999 Hormonal regulation of the NF-κB signaling pathway. Mol Cell Endocrinol 157:1-9
21. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P 2000 Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
22. Safe S, Kim K 2004 Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acids Res Mol Biol 77:1-36
23. Kelly MJ, Qiu J, Ronnekleiv OK 2003 Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system. Ann NY Acad Sci 1007:6-16
24. Levin ER 2005 Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951-1959
25. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER 2004 Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18:2854-2865
26. Watson CS, Campbell CH, Gametchu B 2002 The dynamic and elusive membrane estrogen receptor-α. Steroids 67:429-437
27. Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580
28. Porter W, Wang F, Wang W, Duan R, Safe S 1996 Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol Endocrinol 10:1371-1378
29. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson J-A, Safe S 2000 Ligand-, cell- and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387
30. Safe S, Abdelrahim M 2005 Sp transcription factor family and its role in cancer. Eur J Cancer 41:2438-2448
31. Bardin A, Moll F, Margueron R, Delfour C, Chu ML, Maudelonde T, Cavailles V, Pujol P 2005 Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. Endocrinology 146:760-768
32. Bruning JC, Lingohr P, Gillette J, Hanstein B, Avci H, Krone W, Muller-Wieland D, Kotzka J 2003 Estrogen receptor-α and Sp1 interact in the induction of the low density lipoprotein-receptor. J Steroid Biochem Mol Biol 86:113-121
33. Byrne IM, Flanagan L, Tenniswood MP, Welsh J 2000 Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene. Endocrinology 141:2829-2836
34. Fujita N, Kajita M, Taysavang P, Wade PA 2004 Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Mol Endocrinol 18:2937-2949
35. Schultz JR, Petz LN, Nardulli AM 2005 Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors α and β. J Biol Chem 280:347-354
36. Sun JM, Spencer VA, Li L, Yu CH, Yu J, Davie JR 2005 Estrogen regulation of trefoil factor 1 expression by estrogen receptor and Sp proteins. Exp Cell Res 302:96-107
37. Zhao YL, Han WD, Li Q, Mu YM, Lu XC, Yu L, Song HJ, Li X, Lu JM, Pan CY 2005 Mechanism of transcriptional regulation of LRP16 gene expression by 17-β estradiol in MCF-7 human breast cancer cells. J Mol Endocrinol 34:77-89
38. Jacobson D, Pribnow D, Herson PS, Maylie J, Adelman JP 2003 Determinants contributing to estrogen-regulated expression of SK3. Biochem Biophys Res Commun 303:660-668
39. Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J 2001 Requirement of Sp1 and estrogen receptor α interaction in 17β-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology 142:1546-1553
40. Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A, Petrangeli E 2000 Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter. Endocrinology 141:2266-2274
41. Schultz JR, Petz LN, Nardulli AM 2003 Estrogen receptor α and Sp1 regulate progesterone receptor gene expression. Mol Cell Endocrinol 201:165-175
42. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H 2000 The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275:25781-25790
43. Abdelrahim M, Samudio I, Smith R, Burghardt R, Safe S 2002 Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem 277:28815-28822
44. Kim K, Barhoumi R, Burghardt R, Safe S 2005 Analysis of estrogen receptor α-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol Endocrinol 19:843-854
45. Kim K, Nguyen T, Saville B, Safe S 2003 Domains of estrogen receptor α (ERα) required for ERα/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Mol Endocrinol 17:804-817
46. Higgins KJ, Liu S, Abdelrahim M, Yoon K, Vanderlaag K, Porter W, Metz RP, Safe S 2006 Vascular endothelial growth factor receptor-2 expression is induced by 17β-estradiol in ZR-75 breast cancer cells by estrogen receptor α/Sp proteins. Endocrinology 147:3285-3295
47. Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML 2000 Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29:52, 54
48. Stratman JL, Barnes WM, Simon TC 2003 Universal PCR genotyping assay that achieves single copy sensitivity with any primer pair. Transgenic Res 12:521-522
49. Ashby J 2001 Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A. Environ Health Perspect 109:1091-1094
50. Carroll JS, Brown M 2006 Estrogen receptor target gene: an evolving concept. Mol Endocrinol 20:1707-1714
51. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M 2005 Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43
52. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M 2006 Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297
53. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
54. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
55. Nishidate T, Katagiri T, Lin ML, Mano Y, Miki Y, Kasumi F, Yoshimoto M, Tsunoda T, Hirata K, Nakamura Y 2004 Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol 25:797-819
56. O'Lone R, Frith MC, Karlsson EK, Hansen U 2004 Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18:1859-1875
57. Ciana P, Di Luccio G, Belcredito S, Pollio G, Vegeto E, Tatangelo L, Tiveron C, Maggi A 2001 Engineering of a mouse for the in vivo profiling of estrogen receptor activity. Mol Endocrinol 15:1104-1113
58. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, Lowik C, Maggi A 2003 In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9:82-86
59. Lemmen JG, Arends RJ, van Boxtel AL, Van der Saag PT, van der BB 2004 Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice. J Mol Endocrinol 32:689-701
60. Stoner M, Wang F, Wormke M, Nguyen T, Samudio I, Vyhlidal C, Marme D, Finkenzeller G, Safe S 2000 Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor α and Sp3 proteins. J Biol Chem 275:22769-22779
61. Ngwenya S, Safe S 2003 Cell context-dependent differences in the induction of E2F-1 gene expression by 17β-estradiol in MCF-7 and ZR-75 cells. Endocrinology 144:1675-1685
62. Khan S, Abdelrahim M, Samudio I, Safe S 2003 Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17β-estradiol in breast cancer cells. Endocrinology 144:2325-2335
63. Gaszner M, Felsenfeld G 2006 Insulators: exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 7:703-713
64. Yoon K, Pallaroni L, Stoner M, Gaido K, Safe S 2001 Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three tandem estrogen-responsive elements. J Steroid Biochem Mol Biol 78:25-32
65. Wu F, Safe S 2007 Differential activation of wild-type estrogen receptor α and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells. J Steroid Biochem Mol Biol 103:1-9
66. Di Lorenzo D, Villa R, Biasiotto G, Belloli S, Ruggeri G, Albertini A, Apostoli P, Raviscioni M, Ciana P, Maggi A 2002 Isomer-specific activity of dichlorodyphenyltrichloroethane with estrogen receptor in adult and suckling estrogen reporter mice. Endocrinology 143:4544-4551